Table 3. Associations between plasma cholesteryl ester fatty acids and fatal CHD, matched by age, gender, cohort, and enrollment date.^* .

	Model 1 †	Model 2 ‡	Model 3 §
	OR (95% CI)	OR (95% CI)	OR (95% CI)
Combined cohorts	N = 558
Linoleic acid	0.86 (0.74–1.00)	0.89 (0.74–1.06)	0.95 (0.78–1.15)
Arachidonic acid	1.00 (0.85–1.18)	1.06 (0.88–1.27)	1.11 (0.92–1.35)
Alpha-linolenic acid	1.05 (0.87–1.25)	0.97 (0.79–1.19)	0.92 (0.74–1.15)
EPA	1.02 (0.88–1.20)	1.07 (0.90–1.26)	1.04 (0.86–1.24)
DHA	1.02 (0.87–1.20)	1.09 (0.91–1.31)	1.12 (0.92–1.36)
EPA+DHA	1.03 (0.88–1.20)	1.08 (0.91–1.27)	1.06 (0.88–1.27)

EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid.

^*Values are odds ratios (95% CI) per standard deviation increase, based on conditional logistic models.

^†Crude model, matched for age, gender, cohort, and enrollment date.

^‡Additional adjustment for smoking, BMI, education level, alcohol intake.

^§Additional adjustment for systolic blood pressure, total cholesterol.